Abstract: We analyze selection into screening in the context of recommendations that breast cancer screening start at age 40. Combining medical claims with a clinical oncology model, we document that compliers with the recommendation are less likely to have cancer than younger women who select into screening or women who never screen. We show this selection is quantitatively important: shifting th...
Introduction As rising health care costs force difficult choices for families, employers, and federal, state, and local governments, a range of policy proposals are emerging to address health care spending in the U.S. In this presidential election year, there has been heightened attention on lowering health care costs and making care more affordable, which will likely accelerate with the ele...
HCCI's research on utilization of preventive care services during the coronavirus pandemic was featured in Modern Healthcare. From the article: "A Health Care Cost Institute analysis of data from various payers found mammograms were down 24% and colonoscopies were down 33% as of August." Targeting high-risk cancer patients with genetics As cancer screening rates have dwindled amid the COVID-...
HCCI's President and CEO Niall Brennan was quoted in a Kaiser Health News article on the CMS Transparency in Coverage Final Rule. From the article: " 'If the information is presented to consumers so they realize they are paying a higher price without the benefit of the rebates, you'll get a lot of angry consumers,' said Niall Brennan, CEO of the Health Care Cost Ins...
HCCI's Past the Healthy Marketplace Index reports were mentioned in POLITICO's Pulse Newsletter. From the newsletter: "In reports set to be released this morning, the institute digs into the varying prices of procedures across the country, and even within the same area. For instance, one report probes the actual prices paid for common services across 100 metro areas; the same blood test in T...
